This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_INTRADUCTAL_EXALLC for full statistics.
Carcinoma in situ of breast, intraductal
CD2_INSITU_BREAST_INTRADUCTAL
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3132 |
4. Check minimum number of eventsNone |
3132 |
5. Include endpointsNone |
3132 |
6. Filter based on genotype QC (FinnGen only) |
3132 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D05
- Name in latin
- Carcinoma in situ intraductale mammae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, intraductal
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, intraductal
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3132 | 3132 | - |
| Unadjusted period prevalence (%) | 1.07 | 1.07 | - |
| Median age at first event (years) | 60.34 | 60.34 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2756
- Matched controls
- 27560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
97.2
323.0
441
54
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
775.0
323.0
1341
34
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.0
323.0
1044
1583
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.4
323.0
1022
1249
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
11.9
323.0
817
943
PJA12
NOMESCO Finland
Sentinel node biopsy
26.3
323.0
1802
1845
HAC20
NOMESCO Finland
Total mastectomy
13.7
323.0
887
921
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
17.7
323.0
784
606
HAB99
NOMESCO Finland
Other partial excision of mammary gland
15.4
323.0
573
463
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
4503599627370496.0
323.0
2754
*
HA1AA
NOMESCO Finland
X-ray mammography
10.9
323.0
1243
1928
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
8.1
323.0
844
1425
115
Kela drug reimbursment
Breast cancer
6.4
318.0
1001
2255
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
23.7
308.7
453
227
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
8.3
293.5
727
1146
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
23.8
285.8
418
205
TQW20
NOMESCO Finland
Tatoe
25.1
239.4
344
156
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
12.5
237.3
449
422
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
211.9
1172
4393
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
12.8
211.2
394
355
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.3
210.0
553
914
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
11.1
200.0
401
417
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.6
195.6
427
519
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
7.9
185.8
460
685
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
71.3
184.2
211
32
C50
ICD-10 Finland
Malignant neoplasm of breast
10.1
182.9
385
436
C50.99
ICD-10 Finland
Breast, unspecified
8.6
182.7
424
569
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
10.0
169.6
358
405
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
84.8
162.6
182
23
L02BA01
ATC
tamoxifen; oral
6.3
158.1
460
849
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.3
156.3
343
414
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
153.1
1355
6751
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
11.1
150.6
299
299
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
149.1
617
1685
X76
ICPC
Malignant neoplasm breast female
10.0
145.7
306
340
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.7
138.9
280
287
L02BG04
ATC
letrozole; oral
4.4
136.9
561
1505
ZZR10
NOMESCO Finland
Flap of skin and muscle
19.7
135.5
209
114
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.1
134.8
398
740
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
24.0
120.4
174
77
N63
ICD-10 Finland
Unspecified lump in breast
4.5
120.4
482
1251
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
9.4
115.0
249
289
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
6.7
112.7
307
508
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
33.0
108.8
144
46
HAE99
NOMESCO Finland
Other reconstruction of breast
15.8
108.7
182
123
D05.0
ICD-10 Finland
Lobular carcinoma in situ
72.0
108.5
124
18
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
9.5
107.9
231
262
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
9.2
106.1
232
273
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
21.8
105.6
157
76
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.8
105.6
384
896
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
73.6
105.3
120
17
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
10.9
99.9
198
194
ZZF00
NOMESCO Finland
Graft of adipose tissue
16.4
99.6
164
106
H02AB02
ATC
dexamethasone; systemic
3.3
99.2
589
2107
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
39.3
97.6
124
33
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.4
97.2
389
995
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
468.0
91.8
91
*
Z31.5
ICD-10 Finland
Genetic counselling
4.8
87.4
316
726
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.3
83.5
271
552
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
7.7
83.3
203
283
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
17.1
81.2
131
80
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
8.1
80.8
189
247
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
10.5
78.0
157
158
XX1XN
NOMESCO Finland
Other isotope examination
11.7
75.8
144
129
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.4
74.3
236
467
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
4.9
72.3
252
553
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
12.4
72.1
133
112
ZX080
NOMESCO Finland
Image guided radiotherapy
6.5
68.8
188
308
WX702
NOMESCO Finland
Supraglottic ventilation device
4.0
67.9
296
808
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
12.1
67.5
126
109
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
9.0
67.3
147
171
A04AA02
ATC
granisetron; systemic, transdermal
3.5
67.3
351
1112
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
7.5
65.6
161
226
WX402
NOMESCO Finland
General anaesthesia
2.5
64.8
621
2904
ZXA05
NOMESCO Finland
Left side
2.1
63.4
907
5129
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
6.2
60.9
172
294
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.0
60.6
260
697
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
5.1
60.6
202
421
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
60.4
844
4707
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
4.8
59.1
209
464
R4110
NOMESCO Finland
Physiotherapy
2.1
58.4
904
5245
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.2
58.2
189
382
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
10.3
57.5
116
117
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
6.8
56.5
148
228
HA1SA
NOMESCO Finland
Expansion mammography
16.5
55.9
91
57
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
17.2
54.5
87
52
L03AA13
ATC
pegfilgrastim; parenteral
3.6
53.5
256
752
ZXA00
NOMESCO Finland
Right side
2.0
53.2
929
5609
WZC30
NOMESCO Finland
Teaching
2.4
52.6
495
2263
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
33.2
51.9
68
21
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
6.0
51.4
148
259
N64.9
ICD-10 Finland
Disorder of breast, unspecified
8.3
51.2
117
147
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
50.6
864
5150
TQB05
NOMESCO Finland
Puncture of skin of trunk
9.5
50.6
106
115
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
5.3
50.4
161
319
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
80.2
49.1
55
7
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
5.1
48.7
160
327
ZSZ00
NOMESCO Finland
Primary repair operation
78.8
48.1
54
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.3
47.6
257
828
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
34.6
47.1
61
18
HAD99
NOMESCO Finland
Other plastic operation on breast
11.5
46.9
89
80
N64.5
ICD-10 Finland
Other signs and symptoms in breast
5.0
46.2
156
329
HAD40
NOMESCO Finland
Mastopexy
12.7
46.0
83
67
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
16.4
42.6
69
43
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
6.3
41.6
114
187
X21
ICPC
Breast sympt/compl female other
4.8
41.6
144
312
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
10.0
41.4
84
86
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
40.0
1233
8795
A04AA55
ATC
palonosetron, combinations; systemic
3.5
39.9
198
597
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
6.1
39.7
112
191
NK6AN
NOMESCO Finland
Total body bone isotope imaging
4.7
39.4
139
307
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
12.3
38.9
71
59
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
9.4
38.2
80
87
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
18.5
37.5
58
32
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
13.8
35.3
61
45
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
96.3
34.8
38
*
D24
ICD-10 Finland
Benign neoplasm of breast
4.2
34.5
138
345
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
33.7
311
1387
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
9.4
33.1
69
75
N60.8
ICD-10 Finland
Other benign mammary dysplasias
11.5
33.0
62
55
A04AD12
ATC
aprepitant; systemic
4.0
32.9
137
356
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
10.1
32.3
65
66
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
3.9
31.9
135
356
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
11.8
31.9
59
51
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
6.9
31.7
80
118
N02BE01
ATC
paracetamol; systemic, rectal
2.0
31.5
2469
22319
8500/2-C50.5
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast
161.8
30.7
32
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
17.4
30.6
48
28
L02BG06
ATC
exemestane; oral
4.3
28.9
111
268
D05
ICD-10 Finland
Carcinoma in situ of breast
55.6
28.2
33
6
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
8.6
28.0
61
72
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.5
26.7
80
148
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.7
26.1
76
136
8500/2-C50.2
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast
263.0
25.7
26
*
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
7.8
25.0
58
76
HA1HA
NOMESCO Finland
Tomosynthesis mammography
7.8
24.7
57
74
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
24.5
228
1014
HAA10
NOMESCO Finland
Biopsy of mammary gland
6.1
24.2
67
113
B01AB05
ATC
enoxaparin; parenteral
1.6
23.7
895
6470
X26
ICPC
Fear of breast cancer female
6.5
23.2
61
96
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
6.0
23.1
64
108
QBJ00
NOMESCO Finland
Liposuction in trunk
7.4
23.0
55
76
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.7
22.1
100
281
HAD20
NOMESCO Finland
Liposuction of breast
14.6
21.6
36
25
8500/2-C50.3
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast
221.7
21.6
22
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
8.5
21.6
47
56
HAD00
NOMESCO Finland
Augmentation mammoplasty
31.4
21.5
28
9
Z51.0
ICD-10 Finland
Radiotherapy session
5.4
21.5
65
123
1CD02
NOMESCO Finland
NA
5.0
21.4
69
140
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
211.5
20.6
21
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
9.9
20.6
41
42
N62
ICD-10 Finland
Hypertrophy of breast
2.4
20.5
180
777
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
5.3
20.0
61
117
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
19.8
310
1721
L02BG03
ATC
anastrozole; oral
3.1
19.3
111
374
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
19.2
167
721
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
6.4
19.1
50
79
FM1FN
NOMESCO Finland
Heart function isotope examination
6.3
19.0
50
80
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
70.4
18.7
21
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.5
18.7
67
153
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
17.2
18.7
29
17
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
6.7
18.1
46
70
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
15.4
17.9
29
19
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
5.9
17.7
49
84
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
4.2
17.7
67
162
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
17.4
1096
8692
X19
ICPC
Breast lump/mass female
3.6
17.3
79
225
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
11.6
17.0
31
27
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
4.9
16.9
55
114
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
3.1
16.9
96
321
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.1
16.8
53
106
ZX120
NOMESCO Finland
Intravenous
1.9
16.8
264
1463
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
7.1
16.6
40
57
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
8.0
16.5
37
47
8500/2-C50.1
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast
171.0
16.5
17
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
5.9
16.3
45
77
L03AA14
ATC
lipegfilgrastim; parenteral
3.1
16.0
91
303
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
6.9
15.9
39
57
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
5.9
15.9
44
76
N06AX16
ATC
venlafaxine; oral
1.6
15.8
408
2637
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
5.6
15.7
45
81
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
15.2
196
1008
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
15.0
67
188
ZX112
NOMESCO Finland
Subcutaneous
3.2
15.0
79
253
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.4
14.9
72
216
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
7.6
14.9
34
45
ZZS55
NOMESCO Finland
Distension of tissue expander
25.2
14.7
20
8
N64.8
ICD-10 Finland
Other specified disorders of breast
5.8
14.6
41
72
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
5.2
14.5
44
85
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
14.5
2435
22789
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
7.2
14.3
34
48
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
3.7
14.3
62
171
S18
ICPC
Laceration/cut
1.4
14.1
1086
8826
HA5CB
NOMESCO Finland
Galactography
12.0
14.1
25
21
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
7.8
13.8
31
40
JN4BD
NOMESCO Finland
Extensive body CT
1.7
13.8
288
1751
PJW99
NOMESCO Finland
Other operation on lymphatic system
5.3
13.6
41
79
HA4GT
NOMESCO Finland
Labeling mammary gland pathology with galactographic guidance
14.8
13.6
22
15
9703
FHL
Breast resection
3.7
13.0
55
149
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
5.3
12.8
38
72
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
4.2
12.6
47
114
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
12.6
172
906
1XC03
NOMESCO Finland
NA
6.7
12.5
31
47
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
6.7
12.5
31
47
8504/2-C50.9
ICD-O-3
Encapsulated papillary carcinoma of breast, NOS
130.6
12.4
13
*
HAC25
NOMESCO Finland
Radical mastectomy
5.0
12.1
38
77
J01DB01
ATC
cefalexin; oral
1.4
11.9
2147
19749
HA1AE
SPAT
NA
3.0
11.7
67
228
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
5.0
11.5
36
73
XX1AD
NOMESCO Finland
Other CT-examination
5.5
11.5
33
61
8500/2-C50.8
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast
+∞
11.5
11
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.1
11.4
35
70
WX400
NOMESCO Finland
Inhalation anesthesy
2.2
11.3
119
562
ZXA10
NOMESCO Finland
Bilateral
1.5
11.3
496
3609
L02AE03
ATC
goserelin; implant
4.1
11.3
43
107
XX2ET
NOMESCO Finland
NA
20.1
11.1
16
8
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
13.9
11.0
18
13
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
4.7
10.9
36
78
WX110
NOMESCO Finland
Local anesthesy
1.3
10.9
1757
15740
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
28.1
10.7
14
5
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
5.8
10.7
29
50
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
21.5
10.7
15
7
HA1BA
NOMESCO Finland
Extensive X-ray mammography
3.9
10.7
42
108
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
4.3
10.5
38
90
8543/3-C50.1
ICD-O-3
Paget disease and intraductal carcinoma of breast of central portion of breast
+∞
10.4
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
3.0
10.4
58
196
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
10.2
82
341
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
5.0
10.1
31
62
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
10.0
199
1193
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.6
10.0
68
261
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.1
9.9
51
164
HAB20
NOMESCO Finland
Excision of lactiferous duct
6.3
9.8
25
40
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
100.4
9.4
10
*
X79
ICPC
Benign neoplasm breast female
30.1
9.4
12
*
8501/2-C50.9
ICD-O-3
Comedocarcinoma, noninfiltrating of breast, NOS
+∞
9.4
9
*
HA1WT
NOMESCO Finland
NA
+∞
9.4
9
*
WX704
NOMESCO Finland
Intubation
1.7
9.0
179
1073
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
7.0
9.0
21
30
XX2VW
NOMESCO Finland
Radiologic consultation
5.0
8.9
27
54
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
8.7
361
4819
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
3.7
8.5
35
95
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
6.0
8.4
22
37
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
3.6
8.4
36
101
HA1S1
NOMESCO Finland
Photography of breasts
12.8
8.4
14
11
A04AA01
ATC
ondansetron; systemic, rectal
1.7
8.3
186
1154
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
8.3
158
2442
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.1
8.2
94
465
M05BX04
ATC
denosumab; parenteral
1.7
8.0
156
934
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
4.1
8.0
29
71
A79
ICPC
Malignancy NOS
3.0
7.9
42
140
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
2.3
7.9
67
290
HA1DA
NOMESCO Finland
Restricted mammography
9.4
7.8
15
16
SPAT1269
SPAT
Other puncture and/or drainage
4.0
7.7
29
73
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.5
7.7
34
99
SPAT1153
SPAT
Removal of sutures
1.3
7.6
800
6655
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
6.2
7.5
19
31
D50.1
ICD-10 Finland
Sideropenic dysphagia
13.4
7.4
12
9
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
8.4
7.3
15
18
ZSZ10
NOMESCO Finland
Secondary repair operation
9.4
7.3
14
15
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
7.2
593
4763
QBA00
NOMESCO Finland
Puncture of skin of trunk
4.6
7.2
23
50
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
2.8
7.2
42
149
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
3.6
7.2
30
84
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.1
209
1389
SPAT1152
SPAT
Removal of foreign body from under the skin
2.1
7.1
75
361
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
7.0
16
23
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
13.8
6.9
11
8
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.7
6.8
42
155
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.1
6.8
35
115
ZZR30
NOMESCO Finland
Flap of muscle
5.7
6.7
18
32
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
12.3
6.6
11
9
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
6.6
204
2868
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
3.7
6.6
26
70
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.5
214
1462
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
6.5
147
920
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.9
6.4
35
120
PD2BD
NOMESCO Finland
Extensive CT angiography of pelvic organs
70.0
6.4
7
*
ZZS50
NOMESCO Finland
Insertion of tissue expander
26.7
6.2
8
*
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
6.2
178
1181
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.0
6.2
69
344
WF002
NOMESCO Finland
Radical radiotherapy
2.0
6.1
68
337
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768793) Breast Pathology biopsy report
794
1037
9.92
307.65
1.4
1.3
—
—
—
0
0
(4035726)
1014
2750
4.97
307.65
1.5
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
292
367
8.67
219.61
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
434
837
5.86
218.59
3.3
3.6
u/ml
33.0
30.6
0.09
417
816
(3002256) Pathology report gross observation
865
3741
2.81
132.34
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1938
12886
2.32
109.69
3.8
3.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2105
14813
2.28
99.36
7.4
6.1
umol/l
9.4
10.2
3.38
2029
13993
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2760
21999
3.14
99.03
9.3
7.6
u/l
77.4
78.6
0.97
2668
20606
(3044640) Blood type and Crossmatch panel - Blood
1417
8710
2.14
91.76
2.3
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1835
12457
2.14
91.41
2.6
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
171
338
5.29
82.24
1.1
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2156
16177
2.07
74.57
9.7
9.4
e9/l
3.6
3.9
14.47
1931
14135
(3015377) Calcium [Moles/volume] in Serum or Plasma
1536
10377
1.94
70.38
4.5
3.4
mmol/l
2.4
2.4
5.81
1371
8993
(40758558) Short blood count panel - Blood
1169
7281
1.97
67.36
6.6
6.9
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
118
243
5.01
54.04
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1014
6601
1.79
46.97
2.2
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
577
3248
1.95
41.68
3.5
3.8
ug/l
20.0
23.6
0.13
446
2574
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
195
871
2.32
25.35
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
438
2632
1.77
24.70
1.9
2.1
g/l
0.2
0.2
8.97
420
2480
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1616
13235
1.46
23.01
5.0
5.4
mmol/l
1.2
1.2
2.24
1461
11920
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1736
14571
1.43
20.67
6.0
6.1
mmol/l
1.2
1.2
1.07
1463
12217
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2824
26321
1.74
18.77
14.2
12.8
ml/min/173m2
80.8
78.7
8.41
2491
21642
(40758358) Immune stain study
20
20
10.06
17.59
1.0
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3040
29184
2.42
16.30
18.1
16.1
umol/l
68.1
69.7
4.46
3040
29175
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3045
29298
2.42
15.43
12.9
11.0
u/l
24.0
24.0
0.06
2956
28243
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
87
345
2.57
14.74
1.2
1.4
nmol/l
0.4
0.3
0.86
50
232
(3019550) Sodium [Moles/volume] in Serum or Plasma
2991
28639
1.99
14.42
15.6
15.4
mmol/l
139.8
139.8
0.08
2938
27952
(40761511) CBC panel - Blood by Automated count
2972
28399
1.91
14.39
14.4
13.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
66
231
2.90
14.22
1.1
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
514
3646
1.49
14.15
1.9
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2991
28710
1.93
13.22
15.8
15.5
mmol/l
3.9
3.9
2.44
2933
27970
(3007461) Platelets [#/volume] in Blood
3093
30128
3.14
12.58
23.1
20.7
e9/l
259.6
263.3
2.58
3051
29372
(3024731) MCV [Entitic volume]
3093
30138
3.11
12.37
23.1
20.7
fl
91.3
91.2
0.54
3070
29718
(3035941) MCH [Entitic mass]
3093
30140
3.10
12.33
23.0
20.6
pg
30.2
30.2
0.03
3070
29719
(3026361) Erythrocytes [#/volume] in Blood
3093
30142
3.10
12.29
23.1
20.7
e12/l
4.4
4.4
2.77
3039
29288
(3024561) Albumin [Mass/volume] in Serum or Plasma
1433
12252
1.31
12.27
4.1
4.4
g/l
36.3
35.7
5.17
1302
11323
(3010813) Leukocytes [#/volume] in Blood
3093
30144
3.09
12.25
23.2
20.8
e9/l
6.2
6.5
9.92
3043
29284
(3000963) Hemoglobin [Mass/volume] in Blood
3093
30147
3.09
12.19
23.2
20.8
g/l
131.1
132.1
4.88
3071
29731
(3018418) pH of Serum or Plasma
1075
8891
1.32
11.48
3.9
3.9
ph
7.4
7.4
0.62
191
1690
(3003694) ABO and Rh group [Type] in Blood
845
6780
1.34
11.07
1.3
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
2177
19936
1.30
10.09
3.6
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2864
27403
1.53
9.87
14.4
13.7
mg/l
21.8
21.0
0.65
2250
21534
(3023368) Bacteria identified in Blood by Culture
790
6532
1.28
7.86
3.9
4.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
834
6971
1.27
7.54
3.5
3.6
%
97.0
95.4
1.05
807
6771
(3007853) Bacteria identified in Skin by Aerobe culture
392
2987
1.36
6.97
1.5
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1731
15837
1.21
6.24
3.9
4.1
mmol/l
6.5
6.6
1.94
1640
14815
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1466
13206
1.21
6.22
2.3
2.3
nmol/l
81.2
80.5
0.43
1297
11881
(3019225) pH of Specimen
391
3038
1.33
6.09
4.1
4.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1033
9042
1.21
5.81
3.6
3.2
u/l
28.7
31.9
2.11
987
8560
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
95
576
1.67
5.26
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
662
5590
1.23
5.23
2.9
2.9
mmol/l
2.5
2.5
0.04
576
4908
(3009542) Hematocrit [Volume Fraction] of Blood
2544
24350
1.24
5.10
17.1
15.1
%
38.5
38.9
1.00
1810
16979
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
320
2487
1.32
4.98
2.7
3.9
u/ml
137.1
60.1
0.38
307
2393
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
356
2814
1.30
4.90
2.9
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2373
22590
1.21
4.82
19.3
17.0
%
13.6
13.7
2.78
2347
22094
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
763
6613
1.20
4.58
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
108
723
1.51
4.02
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
183
1356
1.37
3.95
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
173
1274
1.38
3.89
1.3
1.3
iu/l
41.7
39.3
0.41
152
1111
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
64
382
1.69
3.85
1.2
1.2
u/l
62.7
58.5
0.22
44
263
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
441
3721
1.22
3.45
4.6
4.6
%
33.9
33.5
0.38
272
2436
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1854
17513
1.14
3.35
3.1
3.1
u/l
48.4
44.4
0.94
1696
16139
(3032080) INR in Blood by Coagulation assay
1151
10538
1.15
3.30
6.1
7.8
inr
1.1
1.2
2.15
305
3057
(3013512) EKG study
931
8410
1.15
3.22
3.8
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
759
8458
0.86
3.04
3.5
3.8
mg/mmol
3.1
7.5
7.10
394
4765
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
223
0.36
2.91
1.1
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1027
9428
1.13
2.71
5.5
5.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
74
1068
0.69
2.67
1.6
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
38
2.90
2.58
1.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
164
2079
0.78
2.56
2.0
2.2
ug/l
4.9
5.8
0.31
133
1780
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
27
142
1.91
2.55
1.2
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
62
411
1.52
2.54
1.3
1.4
u/l
36.3
40.9
0.45
57
333
(3001186) Copper [Moles/volume] in Serum or Plasma
0
63
0.00
2.42
0.0
1.3
—
17.4
—
0
56
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
27
145
1.87
2.41
1.9
1.8
ug/l
19.8
6.0
0.34
20
95
(3052851) Hemolysis interference index of Serum or Plasma
113
846
1.35
2.41
3.0
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
731
8051
0.88
2.39
2.9
3.1
mg/l
672.9
539.9
0.20
373
4501
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
8
6.26
2.37
1.0
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
761
8346
0.88
2.32
2.8
3.0
mmol/l
6.4
6.4
0.07
626
6938
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
35
207
1.70
2.30
1.3
1.2
u/l
10.7
19.7
1.60
30
180
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
38
234
1.63
2.17
2.2
3.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
130
1.85
2.12
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
130
1.85
2.12
1.5
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
31
2.91
2.07
1.9
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
56
2.33
2.04
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
553
6139
0.88
2.03
1.6
1.7
pmol/l
82589759.2
32565525.0
0.62
448
5033
(3018010) Neutrophils/100 leukocytes in Blood
1381
13058
1.10
2.00
5.5
5.9
%
57.0
56.6
0.56
1275
12125
(3002173) Hemoglobin [Mass/volume] in Arterial blood
269
2288
1.19
2.00
6.2
7.1
g/l
117.9
118.8
0.34
257
2205
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
439
0.59
1.98
1.2
1.5
g/l
0.7
0.7
0.01
17
324
(3021589) Normoblasts [#/volume] in Blood
1300
12263
1.10
1.97
9.4
9.4
e9/l
0.0
0.0
0.76
1052
9988
(3002030) Lymphocytes/100 leukocytes in Blood
1398
13238
1.10
1.95
5.6
6.2
%
27.7
28.8
2.90
1287
12241
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
52
354
1.48
1.95
2.0
2.1
mg/l
16.7
25.0
1.11
14
92
(3017569) Oxygen content in Arterial blood
19
98
1.94
1.95
2.4
2.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
473
0.61
1.94
2.0
1.8
nmol/l
1.1
0.8
1.00
23
392
(3019069) Monocytes/100 leukocytes in Blood
1367
12938
1.10
1.92
5.9
6.4
%
8.5
8.4
0.57
1270
12048
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
97
1262
0.76
1.92
1.4
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
22
3.19
1.88
2.3
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
43
284
1.52
1.87
3.1
3.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
95
724
1.32
1.86
4.9
2.3
%
198.7
194.4
0.15
87
695
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
34
2.65
1.86
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
36
229
1.58
1.84
1.6
1.5
u/l
2.6
5.0
1.12
16
109
(3036489) Thrombin time
122
964
1.28
1.84
2.5
1.8
s
21.1
21.3
0.11
105
828
(3000093) Morphology [Interpretation] in Blood Narrative
32
198
1.62
1.83
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
29
175
1.66
1.82
1.4
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
8
183
0.44
1.80
2.1
2.0
ug/l
1.4
3.9
—
8
165
(3006504) Eosinophils/100 leukocytes in Blood
1357
12868
1.10
1.80
5.6
6.0
%
2.7
2.8
0.76
1250
11918
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
174
1438
1.22
1.78
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
532
0.65
1.74
2.7
2.4
ug/min
126.5
73.0
0.20
22
309
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
262
2256
1.18
1.72
2.7
2.5
ml/min/173m2
66.5
65.2
0.23
84
923
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
24
2.92
1.72
2.3
1.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
177
0.45
1.69
2.4
2.1
ug/l
1.4
3.0
—
8
150
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
316
1.46
1.68
1.1
1.2
u/l
21.4
21.8
0.05
39
253
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
368
0.59
1.66
1.5
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
178
1487
1.21
1.65
6.4
7.4
%
0.8
0.7
4.03
178
1478
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
27
428
0.63
1.64
1.0
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
29
181
1.61
1.63
1.4
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
179
1500
1.21
1.61
6.4
7.3
%
1.3
1.3
0.22
179
1491
(3029937) Albumin [Presence] in Urine by Test strip
672
7280
0.90
1.60
3.8
4.6
estimate
0.0
0.0
1.08
217
2466
(3003396) Base excess in Arterial blood by calculation
318
2798
1.15
1.60
5.6
6.4
mmol/l
1.1
1.3
0.42
259
2210
(3014007) Fractional oxyhemoglobin in Arterial blood
180
1511
1.20
1.60
6.3
7.3
%
95.0
94.0
2.02
180
1506
(3016502) Oxygen saturation in Arterial blood
279
2433
1.16
1.58
6.0
6.8
%
96.5
95.9
1.45
269
2342
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
605
6574
0.90
1.53
1.3
1.3
u/ml
2.0
1.7
0.10
139
1726
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
89
696
1.29
1.50
3.2
2.4
g/l
3.5
3.5
0.12
82
665
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
6
21
2.86
1.50
1.0
1.1
—
17.0
—
0
8
(3022096) Basophils/100 leukocytes in Blood
1312
12497
1.09
1.50
5.6
6.1
%
0.7
0.7
0.08
1211
11574
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
268
1.46
1.46
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
980
10382
0.92
1.44
3.8
4.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
328
0.61
1.43
1.3
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
444
4023
1.12
1.43
2.6
2.7
e6/l
4.5
4.4
0.05
224
2040
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
127
1043
1.23
1.43
2.9
3.2
u/ml
322.6
816.4
0.76
105
886
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
233
2023
1.16
1.42
1.8
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
290
0.58
1.42
1.2
1.4
g/l
7.0
6.9
—
9
202
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
289
0.59
1.41
1.2
1.4
g/l
3.0
2.7
—
9
201
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
289
0.59
1.41
1.2
1.4
g/l
0.6
0.4
—
10
203
(40761535) Cells panel - Urine sediment
197
2287
0.85
1.40
3.0
3.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
337
0.62
1.38
1.4
1.2
mmol/l
6.8
7.7
0.73
15
247
(3020876) Protein [Mass/time] in 24 hour Urine
11
211
0.52
1.38
2.0
1.7
—
0.8
—
0
12
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
121
0.41
1.37
2.6
4.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
27
408
0.66
1.36
1.1
1.1
u/ml
0.5
1.2
0.99
12
146
(1616796) Gas panel - Central venous blood
36
514
0.70
1.36
4.5
3.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
315
2805
1.14
1.36
5.5
6.3
kpa
13.9
12.7
2.50
300
2669
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
315
2808
1.14
1.34
5.5
6.3
kpa
5.2
5.1
0.88
301
2677
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
33
224
1.48
1.33
2.1
2.3
u/field
1.1
2.3
1.17
15
91
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
807
8595
0.92
1.33
1.9
2.1
u/l
134.8
152.1
0.67
743
8015
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
177
1518
1.18
1.28
1.8
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
72
915
0.78
1.28
1.2
1.7
g/l
1.1
1.2
1.76
66
865
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
23
146
1.58
1.25
2.0
2.0
u/field
0.6
2.2
2.92
17
97
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
607
0.74
1.24
1.4
1.4
e6/l
872.1
1486.9
0.36
36
485
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
606
0.74
1.22
1.4
1.3
e6/l
49.4
23.1
0.31
34
454
(3017732) Neutrophils [#/volume] in Blood
229
2013
1.15
1.22
2.9
2.9
e9/l
3.8
4.0
0.61
174
1551
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
14
78
1.80
1.21
1.3
1.1
%
78.3
95.0
—
6
36
(4062490)
18
288
0.62
1.20
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
52
392
1.33
1.19
1.6
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
96
784
1.23
1.18
2.6
2.0
%
94.9
94.2
0.12
89
718
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
52
393
1.33
1.18
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
348
3151
1.12
1.17
2.6
2.5
umol/l
9.4
6.7
1.01
297
2702
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
33
0.00
1.16
0.0
1.2
—
1.6
—
0
33
(3022475) Manganese [Moles/volume] in Blood
5
20
2.50
1.15
1.4
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
30
207
1.45
1.15
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
52
395
1.32
1.14
1.6
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
84
1032
0.81
1.14
3.1
3.5
%
44.3
48.0
0.71
84
1018
(3008898) HLA-B27 [Presence]
75
932
0.80
1.13
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
52
396
1.32
1.13
1.6
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
103
1.65
1.12
2.3
2.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
34
243
1.40
1.09
1.4
5.2
mmol/l
7.3
7.1
0.10
29
205
(4027681)
7
138
0.51
1.09
1.3
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1908
18573
1.07
1.09
4.7
4.8
e6/l
1647.8
2233.8
0.26
24
232
(3037756) Immunofixation for Serum or Plasma
69
549
1.26
1.09
2.0
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
32
2.19
1.08
2.9
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
68
848
0.80
1.07
1.4
1.6
iu/ml
0.2
0.3
0.01
17
174
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
252
2812
0.89
1.06
1.3
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
19
121
1.57
1.05
4.8
3.9
ph
7.4
7.4
—
8
38
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
22
2.27
1.03
2.2
1.9
umol/l
67.4
42.3
—
5
22
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
72
887
0.81
1.03
1.2
1.7
g/l
0.2
0.2
0.23
66
838
(3024354) Oxygen [Partial pressure] in Venous blood
151
1739
0.86
1.02
2.4
2.9
kpa
4.4
4.6
0.34
142
1682
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
335
0.68
1.02
1.0
1.1
u/ml
1.8
1.2
—
9
129
(3051651) Icteric interference index of Serum or Plasma
25
171
1.47
1.02
3.6
3.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
47
1.92
1.02
2.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
263
0.64
1.01
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
345
0.69
1.00
1.0
1.1
u/ml
11.8
2.1
0.75
11
149
(3023410) Appearance of Cerebral spinal fluid
18
274
0.65
1.00
1.6
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
189
2136
0.88
0.99
2.9
3.4
kpa
5.8
5.8
0.17
181
2080
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
274
2476
1.12
0.98
2.9
3.2
ng/l
77.4
80.0
0.26
230
2084
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
508
5445
0.92
0.98
1.3
1.3
u/ml
10.6
14.1
0.60
188
2090
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
29
0.00
0.97
0.0
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
149
1295
1.16
0.97
7.5
8.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
310
1.33
0.96
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
58
724
0.80
0.95
1.6
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
282
0.67
0.95
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
51
399
1.28
0.95
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
52
408
1.28
0.94
1.7
1.4
—
—
—
0
0
(4034850)
75
909
0.82
0.93
8.4
9.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
197
0.61
0.93
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
197
0.61
0.93
1.3
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
276
2504
1.11
0.93
3.3
3.7
mmol/l
1.2
1.2
0.96
250
2174
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
52
1.73
0.92
1.1
1.4
%
3.5
5.1
—
9
44
(3012095) Magnesium [Moles/volume] in Serum or Plasma
475
4426
1.09
0.92
3.0
3.1
mmol/l
0.8
0.8
1.48
436
4086
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
721
0.80
0.92
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
196
0.61
0.92
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
196
0.61
0.92
1.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
160
1816
0.87
0.91
1.3
1.3
u/ml
168.5
167.3
0.01
145
1670
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
40
305
1.32
0.90
4.7
6.8
mg/l
12.3
12.1
0.07
40
282
(4015189)
11
63
1.75
0.90
1.5
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
519
5536
0.93
0.89
1.4
1.4
g/l
2.2
2.3
0.77
255
3182
(3036481) Cortisol [Moles/volume] in Serum or Plasma
240
2651
0.90
0.88
2.4
2.2
nmol/l
384.1
374.3
0.32
214
2434
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
119
1.52
0.88
1.6
2.3
%
37.5
44.2
—
8
43
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
79
1.65
0.88
1.1
1.1
%
74.4
88.0
—
5
35
(3006653) Thiamine [Moles/volume] in Blood
7
130
0.54
0.87
1.0
1.3
nmol/l
130.0
129.6
—
7
130
(3019150) Specific gravity of Urine by Refractometry
560
5949
0.93
0.87
4.0
4.6
kg/l
1.0
1.0
0.19
84
924
(21494755) Public health laboratory ask at order entry panel
169
1904
0.88
0.87
1.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1955
19118
1.06
0.87
4.5
4.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
30
2.00
0.87
1.5
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
192
0.62
0.85
1.5
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
216
0.65
0.85
1.1
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
239
0.67
0.84
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
363
3359
1.09
0.84
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
647
6828
0.93
0.84
2.4
2.4
umol/l
7521.8
4464.4
0.84
541
5834
(3000850) Epithelial cells [#/volume] in Urine
521
5536
0.93
0.82
2.4
2.5
e6/l
7.6
7.5
0.02
442
4842
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
71
850
0.83
0.81
1.2
1.3
u/ml
2.7
8.4
—
7
165
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
201
0.65
0.81
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
409
1.25
0.81
1.5
1.8
u/l
2560.6
1314.0
0.32
16
178
(3018677) aPTT in Platelet poor plasma by Coagulation assay
409
3812
1.08
0.80
2.1
2.0
s
29.2
29.3
0.08
392
3700
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
47
1.70
0.80
1.0
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
248
0.68
0.80
1.0
1.1
u/ml
5.9
2.7
—
5
90
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
838
0.83
0.80
1.2
1.3
u/ml
2.0
5.8
—
5
95
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
363
0.74
0.80
1.1
1.1
iu/ml
32.8
1713.7
—
8
76
(3051387) C reactive protein [Mass/volume] in Capillary blood
70
582
1.21
0.80
3.4
3.5
mg/l
28.1
25.1
0.30
41
346
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
176
0.62
0.79
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
142
1253
1.14
0.79
6.9
7.5
mmol/l
24.4
24.5
0.08
136
1166
(3020961) Endomysium IgA Ab [Titer] in Serum
118
1351
0.87
0.79
1.1
1.1
titre
523.0
220.4
—
5
37
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.3
—
181.3
—
0
15
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
441
4128
1.08
0.78
1.9
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
300
2763
1.09
0.78
4.4
4.3
u/l
256.3
247.3
0.32
280
2609
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
51
628
0.81
0.77
2.2
2.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
40
313
1.28
0.77
3.5
3.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
13
198
0.66
0.76
1.0
1.0
mg/l
324.3
295.5
—
7
170
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
982
10198
0.95
0.76
3.2
3.4
ng/l
46.9
85.1
0.36
649
6739
(44790048)
35
270
1.30
0.76
1.2
1.4
—
—
—
0
0
(44790049)
35
270
1.30
0.76
1.2
1.4
—
—
—
0
0
(44790047)
35
270
1.30
0.76
1.2
1.4
—
—
—
0
0
(44806118)
35
270
1.30
0.76
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
179
1609
1.12
0.75
1.2
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
67
1.64
0.75
1.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
175
1.37
0.74
1.2
1.6
mmol/l
6.3
6.7
0.42
15
114
(3028717) Thiamine [Mass/volume] in Blood
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
54
1.67
0.74
1.1
1.4
%
18.0
20.6
—
9
49
(3014051) Protein [Presence] in Urine by Test strip
60
722
0.83
0.74
2.4
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
177
1964
0.90
0.74
6.1
6.8
mmol/l
8.7
9.1
0.31
165
1877
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
19
266
0.71
0.73
1.4
1.2
—
41.6
—
0
31
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
63
524
1.21
0.73
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
63
524
1.21
0.73
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
108
1.48
0.73
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
193
2129
0.90
0.72
2.9
3.5
mmol/l
2.3
2.1
0.23
162
1784
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
106
0.57
0.72
1.2
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
19
265
0.72
0.72
1.4
1.2
—
54.8
—
0
18
(3011412) CD3 cells [#/volume] in Blood
31
238
1.31
0.70
3.2
2.1
e9/l
1.3
1.1
0.37
19
153
(3021440) Promyelocytes/100 leukocytes in Blood
209
2291
0.91
0.70
3.5
4.0
%
0.2
0.2
0.09
69
588
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
93
1071
0.86
0.70
1.8
2.6
%
0.6
0.6
0.06
86
1024
(3024869) Neuronal Ab [Presence] in Serum
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
145
0.62
0.69
2.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
26
195
1.34
0.69
1.7
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2176
21410
1.05
0.68
4.1
4.4
mm/h
12.8
13.0
0.36
1990
19791
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
27
1.85
0.68
3.6
7.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
110
1.46
0.68
2.8
2.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
75
876
0.85
0.68
1.4
1.7
—
336.9
—
0
45
(3004616) Nuclear Ab [Presence] in Serum
32
408
0.78
0.68
1.4
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
18
127
1.42
0.68
1.4
1.7
pmol/l
15.0
15.3
0.09
12
105
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
152
1689
0.89
0.67
2.4
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
91
0.55
0.67
1.2
1.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
227
2083
1.10
0.66
5.2
5.8
mmol/l
1.2
1.2
0.02
219
2017
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
95
0.53
0.66
2.2
1.6
ug/l
7.9
9.0
—
5
95
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
198
2167
0.91
0.65
3.4
4.0
%
0.1
0.5
0.80
65
502
(4094501)
66
776
0.85
0.65
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
112
989
1.14
0.65
1.7
1.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
40
323
1.24
0.63
1.2
1.4
mosm/kgh2o
276.9
274.6
0.29
29
251
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
112
1.43
0.63
1.9
3.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
53
633
0.83
0.63
3.4
3.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
114
1282
0.89
0.62
1.3
1.3
u/ml
0.2
1.5
—
7
128
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
33
261
1.27
0.62
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
291
0.75
0.62
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
287
2672
1.08
0.62
2.3
2.2
u/l
34.3
38.7
0.66
235
2264
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
10
63
1.59
0.61
1.2
1.4
ng/l
62.1
78.7
—
10
63
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
539
5658
0.94
0.61
1.3
1.3
iu/ml
32.9
35.0
0.13
174
1856
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
222
0.72
0.61
3.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
222
0.72
0.61
3.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
222
0.72
0.61
3.7
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
235
1.28
0.61
1.2
1.4
e6/l
139675.6
75780.1
0.33
14
130
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
191
1.31
0.61
1.5
1.8
%
14.6
13.2
—
9
76
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
472
4477
1.06
0.60
2.5
2.5
e6/l
1.3
1.5
0.61
252
2480
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
267
0.75
0.60
1.0
1.0
u/ml
8.2
2.8
—
5
92
(3023520) Reticulocytes [#/volume] in Blood
183
2000
0.91
0.60
2.2
2.6
e9/l
69.7
71.7
0.37
128
1483
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.9
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.0
—
0
13
(3050794) Legionella sp Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
22
0.00
0.59
0.0
1.2
—
7.2
—
0
14
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
365
0.79
0.58
1.8
2.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
68
787
0.86
0.57
1.5
2.2
ug/l
407.3
727.9
0.51
62
728
(3041096) Erythrocytes [Presence] in Urine by Automated
689
7167
0.95
0.57
3.3
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
361
3403
1.07
0.57
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
136
1502
0.90
0.56
1.7
1.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
87
0.57
0.56
1.0
1.2
pmol/l
246.4
330.9
—
5
69
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
200
2167
0.92
0.56
2.4
2.8
ng/l
132.4
161.4
0.81
175
1984
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
55
1.46
0.56
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
80
700
1.15
0.55
2.1
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
204
2207
0.92
0.55
3.4
3.8
%
0.9
0.6
0.93
55
459
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
79
691
1.15
0.55
1.6
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
54
458
1.18
0.55
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
30
373
0.80
0.55
1.2
1.2
u/l
45.0
25.1
0.68
23
321
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
151
1376
1.10
0.54
1.4
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
60
1.50
0.54
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
303
2846
1.07
0.54
1.7
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
20
151
1.33
0.54
4.1
2.1
e6/l
483.9
469.3
0.05
15
121
(3048879) Bone marrow aspiration report
9
62
1.45
0.53
3.1
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
37
304
1.22
0.53
1.2
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
196
1.28
0.52
1.3
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
96
0.62
0.52
1.5
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
96
0.62
0.52
1.5
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
84
948
0.88
0.51
1.5
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
259
0.77
0.51
1.1
1.1
—
85.0
—
0
5
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
16
214
0.75
0.51
1.0
1.0
u/ml
1.6
0.1
—
5
51
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
25
197
1.27
0.51
1.2
1.4
nmol/l
1.6
1.5
0.26
20
177
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2562
25851
0.95
0.51
5.3
5.7
mmol/mol
39.1
39.5
2.12
2307
23792
(3000285) Sodium [Moles/volume] in Blood
6
41
1.46
0.50
1.3
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
41
1.46
0.50
4.2
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
86
764
1.13
0.49
1.8
2.1
g/l
0.0
0.0
0.00
78
699
(40768806) Pleura Pathology biopsy report
28
225
1.25
0.49
1.1
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
234
2502
0.93
0.49
1.3
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2304
23297
0.96
0.49
4.5
4.6
pmol/l
14.9
14.9
0.18
2070
21250
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
108
0.65
0.48
8.1
11.8
nmol/l
669.6
858.3
—
7
103
(40760892) CBC W Ordered Manual Differential panel - Blood
577
6000
0.95
0.48
3.8
4.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
174
1608
1.09
0.48
4.2
4.9
—
—
—
0
0
(4010399)
200
2149
0.93
0.48
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
166
0.72
0.47
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
60
522
1.15
0.47
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
103
1140
0.90
0.47
1.7
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
59
513
1.15
0.47
1.5
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
27
332
0.81
0.46
5.6
4.8
u/ml
426.5
61.8
—
6
97
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
302
2854
1.06
0.46
1.7
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
150
1628
0.92
0.46
1.7
1.8
g/l
1.2
1.3
0.25
132
1479
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
165
0.73
0.46
1.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
873
8984
0.96
0.46
2.7
2.5
u/l
60.0
57.4
0.68
794
8214
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
749
0.88
0.46
2.7
3.2
u/ml
0.4
0.4
0.06
44
436
(4133840)
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
394
4128
0.95
0.45
1.3
1.3
titre
495.1
570.5
0.37
90
950
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
219
1.23
0.45
3.7
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
192
2059
0.93
0.45
2.8
2.9
g/l
9.8
10.2
0.49
166
1881
(3008152) Bicarbonate [Moles/volume] in Arterial blood
166
1538
1.08
0.44
5.8
6.8
mmol/l
25.1
24.9
0.35
152
1423
(3026389) Candida sp identified in Specimen by Organism specific culture
41
481
0.85
0.44
1.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
84
753
1.12
0.44
1.8
2.1
g/l
0.0
0.0
0.00
77
696
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
500
5202
0.95
0.43
3.3
3.5
ng/l
39.5
259.4
6.39
380
3873
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
118
1078
1.10
0.43
2.1
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
129
0.70
0.43
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
207
2209
0.93
0.43
1.2
1.2
iu/ml
124.4
149.2
0.41
77
874
(3017181) Myelocytes/100 leukocytes in Blood
226
2404
0.94
0.43
3.4
4.0
%
1.4
0.9
1.16
74
640
(3000012) Reticulocyte production index
11
151
0.73
0.42
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
44
378
1.17
0.42
1.3
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
95
0.63
0.42
1.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
173
0.75
0.42
1.1
1.6
umol/l
4.5
8.8
—
8
115
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
176
1.25
0.41
2.3
1.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
631
6520
0.96
0.41
2.2
2.3
mg/l
2.9
3.0
0.50
533
5566
(3018001) Oat IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.1
—
0
7
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
0.8
—
0
10
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
88
795
1.11
0.41
2.0
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
161
0.74
0.41
1.3
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
34
1.47
0.40
1.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
194
0.77
0.40
1.8
2.1
%
10.2
10.9
0.35
15
194
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
18
0.00
0.40
0.0
1.1
—
23.1
—
0
8
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
149
0.74
0.40
1.2
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
12
88
1.37
0.40
1.2
1.2
g/l
43.5
39.4
—
6
40
(46235355) HIV 1 and 2 tests - Meaningful Use set
289
3041
0.95
0.40
1.5
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
160
0.75
0.39
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
95
864
1.10
0.39
1.7
2.0
g/l
38.4
37.8
0.60
80
737
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
303
0.82
0.39
1.0
1.0
u/ml
2.1
1.7
—
5
68
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
260
1.19
0.39
3.1
3.0
%
59.1
58.2
0.07
25
167
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2671
26531
1.05
0.39
5.4
5.5
mu/l
1.9
2.1
1.72
2406
24356
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
178
1.24
0.38
1.9
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
258
0.81
0.38
2.0
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
789
8103
0.96
0.38
1.7
1.7
mmol/l
1.3
1.4
1.06
659
6760
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
107
982
1.09
0.37
1.5
1.7
mg/l
2.3
3.6
0.99
77
717
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
197
1.22
0.37
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
136
0.73
0.37
2.6
2.8
—
20.7
—
0
10
(3000492) Spirometry study
259
2458
1.06
0.37
1.5
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
68
1.32
0.37
6.7
4.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
68
1.32
0.37
6.7
4.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
113
0.71
0.37
1.0
1.1
miu/ml
1119.3
1731.4
—
8
113
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2625
26424
0.96
0.37
4.0
4.1
mmol/l
1.2
1.3
1.99
2334
23947
(3000991) Gas panel - Venous blood
204
1923
1.07
0.37
6.5
7.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
116
0.69
0.37
1.0
1.4
umol/l
2.5
3.5
—
8
104
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
116
0.69
0.37
1.7
2.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
116
0.69
0.37
3.3
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
60
672
0.89
0.36
1.2
1.2
—
26.3
—
0
11
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
130
1400
0.93
0.36
1.7
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
384
1.15
0.36
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
189
1.22
0.36
1.4
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
234
0.81
0.35
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
76
0.66
0.35
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
28
331
0.84
0.35
2.1
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
46
522
0.88
0.35
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
341
0.85
0.34
1.3
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
44
1.36
0.34
3.3
8.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
53
471
1.13
0.34
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
44
386
1.14
0.34
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
82
1.34
0.34
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
663
6449
1.04
0.34
1.5
1.5
nmol/l
22.7
21.9
0.65
539
5427
(3010421) pH of Blood
59
657
0.90
0.33
2.8
3.5
ph
7.4
7.4
0.01
50
543
(3028300) Cannabinoids [Presence] in Urine
44
387
1.14
0.33
1.3
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
118
1.27
0.33
6.9
9.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
312
2991
1.05
0.32
5.4
6.1
mmol/l
104.6
104.3
0.63
305
2934
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
53
592
0.89
0.32
2.4
3.6
%
56.4
57.3
0.20
53
592
(4024509)
39
341
1.15
0.32
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
263
0.84
0.32
1.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
187
0.80
0.32
1.3
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
83
1.33
0.32
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
154
1637
0.94
0.32
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
221
2323
0.95
0.32
3.7
4.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
52
580
0.89
0.31
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
70
768
0.91
0.31
1.3
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
84
773
1.09
0.30
1.1
1.1
u/ml
4.1
8.0
0.45
12
83
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2751
27374
1.04
0.30
4.6
4.7
mmol/l
5.8
5.9
3.68
2446
24946
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
40
353
1.13
0.30
1.8
1.5
%
59.7
55.3
0.32
24
207
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
259
1.16
0.29
2.5
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
222
2117
1.05
0.29
2.7
3.2
pmol/l
4.3
4.4
1.34
192
1870
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
18
217
0.83
0.29
1.9
1.6
u/ml
19.2
21.4
—
5
45
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
377
0.87
0.29
1.5
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
234
2448
0.95
0.29
1.4
1.6
%
1.3
1.4
0.28
196
2139
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
205
1955
1.05
0.28
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
134
1422
0.94
0.28
3.5
3.5
ph
7.4
7.4
1.09
21
197
(3006462) Nitrate [Presence] in Urine
18
149
1.21
0.27
3.0
3.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
39
346
1.13
0.27
3.5
3.2
nmol/l
4.2
21.0
0.53
39
335
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
75
813
0.92
0.27
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
210
2198
0.95
0.27
1.2
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
290
0.86
0.27
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
79
854
0.92
0.27
3.1
3.3
mg/l
26.2
110.9
0.70
67
695
(4281824)
44
490
0.90
0.27
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
287
2981
0.96
0.27
1.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
139
0.79
0.27
4.6
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
139
0.79
0.27
4.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
139
0.79
0.27
4.6
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
139
0.79
0.27
4.6
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
136
1440
0.94
0.26
3.5
3.5
kpa
5.2
5.2
0.26
130
1338
(3044290) Cell count panel - Cerebral spinal fluid
50
552
0.90
0.26
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
79
853
0.92
0.26
3.1
3.3
mg/l
41.6
42.8
0.02
69
692
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1148
11655
0.98
0.26
2.6
2.8
ug/l
103.6
106.7
0.24
1033
10724
(3020891) Body temperature
91
976
0.93
0.26
3.1
4.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
136
1437
0.94
0.25
3.2
3.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
88
820
1.08
0.25
1.8
2.1
g/l
0.0
0.0
0.36
80
751
(3015183) Erythrocyte sedimentation rate
13
105
1.24
0.24
1.0
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
38
340
1.12
0.24
1.1
1.5
—
22.3
—
0
12
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
36
321
1.12
0.24
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
378
3668
1.03
0.24
2.3
2.4
g/l
2.4
2.4
0.22
334
3388
(3045788) Cell count panel - Pleural fluid
25
217
1.15
0.24
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
133
1.20
0.24
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
236
1.15
0.24
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
236
1.15
0.24
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
236
1.15
0.24
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
92
861
1.07
0.24
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
424
4358
0.97
0.24
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
293
1.13
0.24
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
871
1.07
0.24
1.1
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
1043
0.94
0.23
1.5
1.7
g/l
1.7
1.6
0.37
77
895
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
466
1.10
0.23
5.8
4.6
iu/ml
1316.3
277.4
—
6
60
(4146454)
33
294
1.12
0.23
2.1
2.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
125
0.80
0.23
1.2
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
97
1.24
0.23
1.3
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
217
2087
1.04
0.22
1.9
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
48
438
1.10
0.22
2.7
3.0
%
1.1
1.4
0.46
39
342
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
91
0.77
0.22
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
92
0.76
0.22
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
40
1.25
0.22
3.6
8.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
189
0.85
0.22
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
80
855
0.93
0.22
1.9
1.8
iu/l
4.1
4.6
0.21
33
301
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
59
638
0.92
0.22
1.5
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
14
116
1.21
0.22
1.2
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
349
3391
1.03
0.22
2.4
2.4
%
20.8
21.8
0.72
292
2871
(42529406) Shigella sp [Presence] in Stool by Culture
93
875
1.06
0.21
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
234
2257
1.04
0.21
2.2
2.6
g/l
66.7
66.6
0.06
209
2037
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
596
0.92
0.21
1.2
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
16.0
—
0
11
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
314.5
—
0
11
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
10.5
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
2.4
—
2.9
—
0
12
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
12
0.00
0.21
0.0
12.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.0
—
0
6
(40760410) HLA-B [Type] by High resolution
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
49
1.22
0.20
1.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
198
1908
1.04
0.20
2.0
2.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
724
7119
1.02
0.19
2.8
2.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
101
957
1.06
0.19
1.3
1.4
ug/g
305.8
284.6
0.52
59
546
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
97
918
1.06
0.19
3.5
3.6
mmol/l
25.2
25.1
0.15
87
847
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
197
0.86
0.19
1.1
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
182
1890
0.96
0.19
1.3
1.3
au/ml
64.9
44.1
—
9
81
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
279
1.11
0.19
2.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1595
16090
0.98
0.19
2.7
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
145
1389
1.05
0.19
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
186
0.86
0.19
1.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1192
11785
1.02
0.19
2.0
2.0
pmol/l
102.6
99.2
1.32
511
5463
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
18
207
0.87
0.19
1.0
1.0
ng/l
352.5
368.8
0.11
13
144
(3048689) Calprotectin [Mass/mass] in Stool
352
3610
0.97
0.19
2.0
2.0
ug/g
105.0
124.3
0.76
248
2790
(3023199) Leukocytes [#/volume] in Pleural fluid
30
270
1.11
0.18
1.2
1.4
e6/l
3782.8
2354.7
0.35
24
201
(3017704) Immunofixation for Urine
16
137
1.17
0.18
1.5
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
52
560
0.93
0.18
1.7
1.7
mu/l
363.1
333.2
0.18
47
495
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
156
1.15
0.18
1.5
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
109
1.19
0.18
1.6
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
357
1.09
0.18
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
68
638
1.07
0.18
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
61
1.15
0.17
9.0
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
145
1508
0.96
0.17
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
88
927
0.95
0.17
1.5
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
53
494
1.07
0.17
3.6
3.3
nmol/l
0.7
0.8
1.72
37
378
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
201
2076
0.97
0.17
2.4
2.4
au/ml
42.7
23.8
0.67
13
98
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
928
9396
0.98
0.17
2.8
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
511
5016
1.02
0.17
2.4
2.7
mosm/kgh2o
490.4
503.2
0.72
414
4269
(3032057) Clostridioides difficile [Presence] in Stool
5
66
0.76
0.17
1.4
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
69
0.72
0.17
1.6
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
17
148
1.15
0.17
1.6
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
152
0.85
0.17
1.4
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
234
1.11
0.16
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
234
1.11
0.16
1.2
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
68
1.18
0.16
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
101
1.19
0.16
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
162
0.86
0.16
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
37
401
0.92
0.16
1.4
1.2
u/ml
5.3
4.0
0.24
13
146
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1024
1.05
0.16
1.7
2.2
g/l
10.1
10.0
0.05
87
851
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
116
1209
0.96
0.15
2.0
2.0
u/l
39.4
40.5
0.26
102
1075
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
235
1.11
0.15
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
216
1.11
0.15
1.3
1.5
g/l
1.0
1.0
0.19
24
216
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
1045
1.04
0.15
1.8
2.2
g/l
3.2
3.1
0.41
85
799
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
161
0.87
0.15
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
255
0.90
0.15
1.5
1.5
%
36.8
39.1
0.08
13
146
(3024928) Oxygen saturation in Venous blood
45
482
0.93
0.15
1.9
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
87
911
0.95
0.14
2.0
1.9
ug/l
3.2
1.8
0.58
75
811
(1761482) Bacteria [#/volume] in Urine by Culture
70
664
1.06
0.14
3.4
4.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
409
0.93
0.14
1.1
1.2
u/ml
296.1
286.6
0.07
23
241
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
285
1.09
0.14
1.8
2.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
139
0.86
0.14
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
62
587
1.06
0.14
2.1
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
19
212
0.90
0.14
1.0
1.0
ng/l
51.1
49.9
0.05
14
147
(3021901) Oxygen saturation in Capillary blood
37
398
0.93
0.14
3.1
2.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
243
0.90
0.13
6.9
6.2
—
—
—
0
0
(1002224) Polysomnography panel
98
1021
0.96
0.13
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
122
1.15
0.13
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
122
1.15
0.13
1.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
122
1.15
0.13
1.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
673
6643
1.02
0.13
3.4
4.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
97
931
1.04
0.13
1.9
2.2
g/l
0.5
0.6
0.11
82
802
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
412
1.07
0.13
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
346
0.92
0.13
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
598
1.05
0.13
1.9
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
109
0.83
0.13
5.4
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
109
0.83
0.13
5.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
109
0.83
0.13
5.4
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
106
1021
1.04
0.13
5.0
5.5
%
0.9
0.9
0.16
98
957
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2821
28148
1.02
0.13
5.1
5.2
mmol/l
2.9
2.9
0.21
2530
25792
(3000475) Leukocytes [#/volume] in Synovial fluid
74
707
1.05
0.12
1.8
1.6
e6/l
12752.9
9412.7
0.46
53
507
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
30
324
0.93
0.12
1.1
1.1
g/l
1.4
1.5
0.43
24
284
(3015076) Soybean IgE Ab [Units/volume] in Serum
12
104
1.15
0.12
1.0
1.0
—
0.2
—
0
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
61
641
0.95
0.12
1.3
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
52
549
0.95
0.12
3.0
3.6
mmol/l
2.3
2.8
0.96
41
395
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
137
0.88
0.12
1.4
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
137
0.88
0.12
2.1
2.8
u/ml
715.5
1420.6
0.83
12
137
(36660697) Celiac disease serology panel - Serum
247
2418
1.02
0.12
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
133
1371
0.97
0.12
3.4
3.5
mmol/l
1.8
2.0
0.30
111
1066
(3045414) Leukocytes [Presence] in Urine
135
1391
0.97
0.11
1.9
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
637
6296
1.01
0.11
1.8
1.7
mg/l
1.0
1.1
0.66
482
4836
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
209
0.91
0.11
1.0
1.0
ng/l
759.9
726.2
0.10
14
141
(3022948) Iron [Moles/volume] in Serum or Plasma
395
4011
0.98
0.11
2.3
2.4
umol/l
12.2
12.9
1.10
360
3707
(3018405) Lactate [Moles/volume] in Arterial blood
88
848
1.04
0.11
3.0
3.5
mmol/l
1.4
1.3
0.10
88
833
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2736
27416
0.98
0.10
4.5
4.6
mmol/l
1.6
1.6
5.49
2457
25111
(3016879) Cocaine [Presence] in Urine
37
349
1.06
0.10
1.4
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
197
0.91
0.10
1.5
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
135
0.89
0.09
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
412
0.95
0.09
1.3
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
371
0.94
0.09
1.3
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
207
0.92
0.09
1.4
1.2
u/ml
2.2
1.4
0.18
11
86
(3003338) MCHC [Mass/volume]
2272
22651
1.01
0.09
20.5
18.1
g/l
330.3
330.4
0.36
2261
22508
(3002523) Influenza virus A Ag [Presence] in Specimen
36
340
1.06
0.09
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
213
1.08
0.09
1.1
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
106
1030
1.03
0.09
3.4
3.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
56
1.07
0.08
1.5
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
56
1.07
0.08
1.2
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
36
341
1.06
0.08
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
105
1022
1.03
0.08
4.7
5.3
%
1.6
1.6
0.07
97
955
(3009261) Glucose [Presence] in Urine by Test strip
1396
13892
1.01
0.08
3.6
4.1
estimate
0.0
0.0
1.08
224
2474
(3003129) Base excess in Capillary blood by calculation
5
60
0.83
0.08
3.4
1.8
mmol/l
3.7
1.3
—
5
53
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
146
1.10
0.08
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
724
7298
0.99
0.08
2.9
3.0
e6/l
0.5
0.4
0.14
513
5433
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
460
1.04
0.08
1.2
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
14
127
1.10
0.08
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
127
1.10
0.08
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
68
1.03
0.07
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
68
1.03
0.07
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
68
1.03
0.07
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
68
1.03
0.07
1.1
1.1
—
—
—
0
0
(4211845)
18
166
1.08
0.07
3.0
3.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
70
0.86
0.07
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
70
0.86
0.07
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
42
439
0.96
0.07
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
451
1.04
0.07
1.3
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
75
1.07
0.07
4.3
1.8
ug/l
2.3
1.3
—
8
70
(3018095) Leukocytes [#/volume] in Urine
938
9437
0.99
0.07
3.5
3.6
e6/l
128.5
109.1
0.22
606
6445
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
333
1.05
0.07
1.4
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
83
807
1.03
0.07
5.9
6.6
mmol/l
1.1
1.2
1.81
70
714
(40765096) Chromosome analysis panel by Banding
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1419
14133
1.01
0.07
5.4
5.9
e9/l
1.8
1.9
3.53
1218
12391
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
397
0.96
0.07
1.3
1.3
u/ml
76.5
120.4
—
6
86
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
437
0.96
0.06
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
99
1.11
0.06
2.2
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
142
0.92
0.06
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
142
0.92
0.06
1.3
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
457
0.96
0.06
1.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
111
0.90
0.06
1.0
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
60
582
1.03
0.06
7.1
7.6
mmol/l
10.2
11.0
1.80
52
525
(3018572) Chloride [Moles/volume] in Blood
60
582
1.03
0.06
7.1
7.6
mmol/l
106.4
105.1
1.62
52
525
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2765
27615
1.01
0.06
4.5
4.6
mmol/l
5.0
4.9
1.96
2492
25443
(3016018) Differential panel - Cerebral spinal fluid
27
284
0.95
0.06
1.5
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
27
284
0.95
0.06
1.9
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
577
0.97
0.05
2.4
2.1
g/l
132.7
126.3
1.13
38
399
(3014271) Vancomycin [Susceptibility]
14
129
1.09
0.05
3.3
2.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
129
1.09
0.05
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
782
7779
1.01
0.05
2.9
3.1
e6/l
76.0
63.3
0.11
558
5854
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
425
1.04
0.05
1.1
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1381
13764
1.01
0.05
4.9
5.4
estimate
0.0
0.0
0.80
214
2446
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
159
1.07
0.05
1.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
108
1099
0.98
0.05
3.1
3.9
mmol/l
24.7
24.4
0.29
94
989
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
42
434
0.97
0.05
1.2
1.3
nmol/l
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
364
3612
1.01
0.04
5.4
6.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
91
1.10
0.04
1.1
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
18
190
0.95
0.04
1.2
1.3
mmol/l
6.5
6.6
0.01
18
176
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
42
408
1.03
0.04
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
60
613
0.98
0.03
3.7
3.2
u/ml
97.7
919.2
1.17
55
554
(3035350) Ketones [Presence] in Urine by Test strip
1358
13612
1.00
0.03
3.5
4.0
estimate
0.0
0.0
0.50
220
2447
(3001604) Monocytes [#/volume] in Blood
1376
13791
1.00
0.03
5.4
5.8
e9/l
0.5
0.6
0.44
1158
11845
(3004716) Salmonella sp identified in Stool by Organism specific culture
141
1394
1.01
0.03
1.2
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
522
0.98
0.03
2.9
2.5
%
17.1
16.0
1.03
26
261
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
37
381
0.97
0.03
1.1
1.1
u/ml
5.6
3.1
0.25
19
156
(3003458) Phosphate [Moles/volume] in Serum or Plasma
338
3359
1.01
0.03
4.0
4.8
mmol/l
1.0
1.0
0.12
308
3077
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
67
658
1.02
0.03
1.3
1.3
miu/ml
281.4
230.9
0.45
34
313
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
53
519
1.02
0.03
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
211
1.04
0.03
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
249
0.96
0.02
1.4
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
51
500
1.02
0.02
2.3
2.8
mmol/l
7.5
7.5
0.02
51
488
(3028707) Methadone [Presence] in Urine by Screen method
18
188
0.96
0.02
1.1
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
266
2646
1.01
0.02
2.2
2.6
%
1.7
1.9
2.08
229
2340
(3000034) Microalbumin [Mass/volume] in Urine
27
262
1.03
0.02
2.5
2.7
mg/l
6.3
21.9
1.93
21
172
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
137
0.95
0.01
5.4
2.4
e6/l
373.9
730.3
—
7
58
(3019309) Folate [Moles/volume] in Red Blood Cells
511
5097
1.00
0.01
1.8
1.7
nmol/l
1049.2
1200.7
3.53
359
3816
(3013115) Eosinophils [#/volume] in Blood
1433
14345
1.00
0.01
5.6
6.1
e9/l
0.2
0.2
2.27
1230
12530
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
207
0.97
0.01
2.2
2.4
—
—
—
0
0
(4268621)
27
277
0.97
0.01
2.7
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
191
1919
1.00
0.01
3.3
3.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
1103
1.01
0.00
1.8
2.2
g/l
3.7
3.7
0.03
84
778
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
1103
1.01
0.00
1.8
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
123
1223
1.01
0.00
1.6
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
15
144
1.04
0.00
1.3
1.4
u/l
11.3
12.3
0.28
15
136
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
176
0.97
0.00
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
294
1.02
0.00
1.5
1.4
—
—
—
0
0
(4306422)
41
404
1.02
0.00
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
970
9707
1.00
0.00
3.1
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
79
796
0.99
0.00
1.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
1104
1.01
0.00
1.8
2.2
g/l
7.5
7.6
0.06
87
819
(3006315) Basophils [#/volume] in Blood
1385
13856
1.00
0.00
5.5
5.9
e9/l
0.0
0.0
1.46
1157
11896
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
135
0.96
0.00
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
121
0.99
0.00
1.4
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
27
265
1.02
0.00
1.8
1.4
e6/l
8995.3
104793.9
1.41
19
174
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
275
1.02
0.00
1.4
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
19
191
0.99
0.00
2.4
2.0
%
31.8
40.4
—
6
24
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
221
1.00
0.00
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
405
0.99
0.00
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
229
1.00
0.00
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
435
1.01
0.00
1.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
44
445
0.99
0.00
2.3
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
76
759
1.00
0.00
1.6
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
88
879
1.00
0.00
2.9
2.8
g/l
0.2
0.3
1.89
27
292
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
96
1.04
0.00
1.1
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
294
0.99
0.00
1.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
324
0.99
0.00
1.3
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
53
526
1.01
0.00
2.3
2.7
mmol/l
1.4
1.6
1.02
53
511
(3003181) Sodium [Moles/volume] in Urine
54
544
0.99
0.00
1.1
1.3
mmol/l
63.2
59.9
0.21
43
426
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
17
168
1.01
0.00
1.2
1.4
—
1.6
—
0
12
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
764
7639
1.00
0.00
2.6
2.8
ng/l
829.8
1033.9
1.36
635
6510
(44813793)
22
218
1.01
0.00
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
408
1.00
0.00
1.3
1.2
u/ml
3.8
3.3
0.08
13
117
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
450
4497
1.00
0.00
1.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
325
3248
1.00
0.00
20.9
21.6
inr
1.3
1.3
0.01
41
473
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
113
0.97
0.00
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
153
0.98
0.00
1.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
63
0.95
0.00
1.2
1.4
%
57.3
63.8
—
6
53
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
4.7
—
336.6
—
0
7
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
3.8
—
1.4
—
0
6
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
0.2
—
0
9
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
2.0
—
0
7
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
85
0.94
0.00
1.4
2.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
51
0.98
0.00
3.6
5.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017950) Salicylates [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
410
1.00
0.00
1.1
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
61
0.98
0.00
1.2
1.7
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.3
—
0
5
(3027923) C peptide [Moles/volume] in Serum or Plasma
14
140
1.00
0.00
1.2
1.5
nmol/l
1.0
1.2
—
9
109
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1308.0
—
0
5
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
270.3
—
0
8
(4198724)
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
7
70
1.00
0.00
1.4
1.7
u/l
20.7
90.7
—
7
64
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
92
0.98
0.00
1.2
1.1
iu/ml
144.0
192.5
—
9
92
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_INTRADUCTAL – Carcinoma in situ of breast, intraductal
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).